Taiwan - Delayed Quote TWD
Vizionfocus Inc. (4771.TW)
210.00
-2.50
(-1.18%)
At close: 1:30:16 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,044,509
3,002,007
2,572,202
1,834,321
1,419,688
Cost of Revenue
1,840,157
1,823,088
1,546,863
1,136,893
927,876
Gross Profit
1,204,352
1,178,919
1,025,339
697,428
491,812
Operating Expense
323,058
306,764
292,697
210,933
183,245
Operating Income
881,294
872,155
732,642
486,495
308,567
Net Non Operating Interest Income Expense
-9,783
-10,363
-9,829
-9,234
-7,966
Pretax Income
923,225
920,310
834,502
381,571
329,685
Tax Provision
189,509
191,337
178,772
64,921
51,594
Net Income Common Stockholders
679,491
669,589
562,282
312,991
234,133
Diluted NI Available to Com Stockholders
679,491
669,589
562,282
312,991
234,133
Basic EPS
11.71
11.81
10.77
6.02
4.64
Diluted EPS
11.54
11.61
10.49
5.85
4.51
Basic Average Shares
57,856.18
56,708
52,187
52,008
50,512
Diluted Average Shares
58,704.98
57,655
53,593
53,461
51,951
Total Expenses
2,163,215
2,129,852
1,839,560
1,347,826
1,111,121
Net Income from Continuing & Discontinued Operation
679,491
669,589
562,282
312,991
234,133
Normalized Income
674,762.35
657,136.47
484,196.49
412,913.45
227,390.86
Interest Income
18,398
18,473
10,140
3,434
1,567
Interest Expense
28,181
28,836
19,969
12,668
9,533
Net Interest Income
-9,783
-10,363
-9,829
-9,234
-7,966
EBIT
951,406
949,146
854,471
394,239
339,218
EBITDA
1,321,112
1,304,499
1,133,299
628,497
508,012
Reconciled Cost of Revenue
1,840,157
1,823,088
1,546,863
1,136,893
927,876
Reconciled Depreciation
369,706
355,353
278,828
234,258
168,794
Net Income from Continuing Operation Net Minority Interest
679,491
669,589
562,282
312,991
234,133
Total Unusual Items Excluding Goodwill
5,950
15,721
99,374
-120,409
7,993
Total Unusual Items
5,950
15,721
99,374
-120,409
7,993
Normalized EBITDA
1,315,162
1,288,778
1,033,925
748,906
500,019
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,221.35
3,268.47
21,288.49
-20,486.55
1,250.86
12/31/2021 - 3/11/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6782.TW Visco Vision Inc.
182.00
-1.09%
6491.TW Pegavision Corporation
351.50
-1.26%
1565.TWO St.Shine Optical Co.,Ltd.
171.50
-1.72%
4737.TW Bionime Corporation
68.20
-1.30%
1786.TW SciVision Biotech Inc.
97.00
-1.72%
1752.TW Nang Kuang Pharmaceutical Co., Ltd.
36.70
-0.41%
1783.TW Maxigen Biotech Inc.
41.85
-0.71%
4107.TWO Bioteque Corporation
120.50
-0.82%
5312.TWO Formosa Optical Technology Co.,Ltd.
147.50
+2.79%
6612.TWO ICARES Medicus, Inc.
120.50
+1.26%